全文获取类型
收费全文 | 1482篇 |
免费 | 87篇 |
国内免费 | 65篇 |
专业分类
耳鼻咽喉 | 12篇 |
儿科学 | 58篇 |
妇产科学 | 22篇 |
基础医学 | 160篇 |
口腔科学 | 24篇 |
临床医学 | 191篇 |
内科学 | 412篇 |
皮肤病学 | 23篇 |
神经病学 | 115篇 |
特种医学 | 245篇 |
外科学 | 97篇 |
综合类 | 30篇 |
一般理论 | 2篇 |
预防医学 | 84篇 |
眼科学 | 8篇 |
药学 | 97篇 |
1篇 | |
中国医学 | 2篇 |
肿瘤学 | 51篇 |
出版年
2023年 | 6篇 |
2022年 | 8篇 |
2021年 | 19篇 |
2020年 | 5篇 |
2019年 | 14篇 |
2018年 | 22篇 |
2017年 | 13篇 |
2016年 | 17篇 |
2015年 | 42篇 |
2014年 | 39篇 |
2013年 | 52篇 |
2012年 | 74篇 |
2011年 | 62篇 |
2010年 | 53篇 |
2009年 | 40篇 |
2008年 | 53篇 |
2007年 | 83篇 |
2006年 | 41篇 |
2005年 | 45篇 |
2004年 | 37篇 |
2003年 | 35篇 |
2002年 | 40篇 |
2001年 | 27篇 |
2000年 | 28篇 |
1999年 | 43篇 |
1998年 | 59篇 |
1997年 | 41篇 |
1996年 | 64篇 |
1995年 | 55篇 |
1994年 | 47篇 |
1993年 | 52篇 |
1992年 | 19篇 |
1991年 | 23篇 |
1990年 | 29篇 |
1989年 | 34篇 |
1988年 | 44篇 |
1987年 | 41篇 |
1986年 | 31篇 |
1985年 | 38篇 |
1984年 | 19篇 |
1983年 | 12篇 |
1982年 | 17篇 |
1981年 | 23篇 |
1980年 | 21篇 |
1979年 | 7篇 |
1978年 | 10篇 |
1977年 | 17篇 |
1976年 | 8篇 |
1975年 | 10篇 |
1964年 | 2篇 |
排序方式: 共有1634条查询结果,搜索用时 15 毫秒
1.
2.
3.
Phase III clinical trial with a new oral contraceptive containing 150 micrograms desogestrel and 20 micrograms ethinylestradiol. 总被引:1,自引:0,他引:1
Results are presented of a Phase III international multicentre trial to study the effect of a new low-dose oral contraceptive (OC) containing 20 micrograms ethinylestradiol and 150 micrograms desogestrel (Mercilon) regarding efficacy, cycle control, blood pressure, and acceptability. Altogether 1,684 women from 12 European countries were included in the study. Four pregnancies occurred, 3 of them patient failures, one tablet failure. The overall Pearl Index was 0.20. The frequency of irregular bleeding was comparable to that recorded with other commonly used low-dose OCs. No serious side effects occurred. The incidence of the most frequently reported subjective side effects--headache, nausea and breast tension--was already low after the first cycle of treatment and decreased to below pretreatment levels with continued use. There was a small increase in mean body weight, which was confined essentially to young women. The preparation did not affect the mean systolic or diastolic blood pressure. This new preparation has thus proved to be an effective, safe and well-accepted ultra low-dose oral contraceptive. 相似文献
4.
5.
6.
7.
8.
Cordula C M Pitz Aart Brutel de la Rivière Henry A van Swieten Vincent A M Duurkens Jan-Willem J Lammers Jules M M van den Bosch 《European journal of cardio-thoracic surgery》2004,26(1):202-208
Due to its localisation in the apex of the lung with invasion of the lower part of the brachial plexus, first ribs, vertebrae, subclavian vessels or stellate ganglion, a superior sulcus tumour causes characteristic symptoms, like arm or shoulder pain or Horner's syndrome. If rib invasion is the only feature, lysis of the rib must be evident on the chest radiograph; otherwise the tumour cannot be defined as a Pancoast tumour. It is important to adequately stage the tumour, because staging significantly influences survival. Survival is better for T3 than T4 tumours and mediastinal lymph node involvement has been found to be a negative prognostic factor. Also Horner's syndrome and incompleteness of resection worsen survival. The management of superior sulcus tumours has evolved over the past 50 years. Before 1950 it was considered to be inoperable and uniformly fatal. Shaw and Paulson introduced combined modality treatment and for many years, this combination of radiotherapy and surgery was the treatment of choice with a mean 5-year survival of approximately 30%. Postoperative radiotherapy or brachytherapy does not improve survival in patients with complete or incomplete resection. The tumour can be resected through the classic posterior Shaw-Paulson approach or the newer anterior transcervical approach, introduced by Dartevelle. This method facilitates better exposure of the extreme apex of the lung, brachial plexus and subclavian vessels. Regarding the extent of pulmonary resection, en bloc resection of the involved ribs with a lobectomy is recommended. Recent multimodality studies, involving chemoradiotherapy and surgical resection, show promising results regarding completeness of resection, local recurrence and survival, provided that appropriate staging has been carried out. However, careful patient selection and adequate perioperative management with protection of the bronchial stump or anastomosis are important to achieve reasonable rates of morbidity and mortality. As brain metastases remain one of the most common forms of relapse, further studies are needed to examine the role of prophylactic cranial irradiation in patients with complete resection. Also the addition of other chemotherapy agents or biologic agents such as angiogenesis inhibitors or tyrosine kinase inhibitors gives a new perspective in the treatment of Pancoast tumours. 相似文献
9.
10.